Blog and news

White Paper | 14.09.2021

Impact of Obesity in Nonalcoholic Fatty Liver Disease & Metabolic Syndrome

Article | 12.08.2021

Liver Health Experts and Echosens Technology Featured on eHealth Radio Network

Article | 12.08.2021

New EASL Clinical Practice Guidelines Make Unprecedented Recommendation for Non-Invasive FibroScan^® and Care Management

Press Release | 09.08.2021

Echosens Highlights New EASL Clinical Practice Guidelines

Article | 03.08.2021

Douglas Dieterich, M.D., discusses role of FibroScan^® in the diagnoses of chronic liver disease

Article | 28.07.2021

Non-Invasive Liver Exam Identifies Asymptomatic Liver Disease, Provides Follow-Up for Hepatitis C Virus

Article | 26.07.2021

NICE Experts Endorse FibroScan^®: Cost-Effective Liver Exam

Article | 26.07.2021

Lancet Study: FibroScan^® Identifies Severe Fibrosis/Cirrhosis for Earlier Diagnosis

Article | 23.07.2021

Population-Based Return on Investment of Deploying Transient Elastography

Article | 09.07.2021

Echosens CEO Discusses How Company Helps Fight Liver Disease Epidemic

Webinar | 05.07.2021

Enhancing the management of NAFLD patients with FibroScan^®-based scores

Press Release | 24.06.2021

Leading Liver Disease Researchers Present at EASL International Liver Congress™ 2021

Article | 21.06.2021

Celebrating 2 decades of liver health

Press Release | 09.06.2021

Echosens Launches New FibroScan^®-based Scores Agile 3+ & Agile 4

Article | 31.05.2021

Help Support First Annual Liver Health Matters Month!